Feb 4, 2026
Caplyta
(lumateperone) is an atypical antipsychotic approved by the initially in December 2019 for schizophrenia and later for bipolar depression; it is also indicated as adjunctive therapy for major depressi...
Your fact-checks will appear here
The side effects associated with antipsychotic medications, including somnolence, dizziness, nausea, and dry mouth.